Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 21, 2015 1:48 PM ET

Pharmaceuticals

Company Overview of Transcept Pharmaceuticals, Inc.

Executive Profile

Alan C. Mendelson J.D.

AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 20 different industries.

See Board Relationships
64--

Background

Mr. Alan C. Mendelson, J.D. serves as Corporate Secretary and Corporate Counsel at Agensys, Inc. Mr. Mendelson serves as General Counsel and Secretary of Optivia Biotechnology Inc. He serves as Advisor at PicoField Technologies, Inc. He serves as a Secretary of Mellanox Technologies, Ltd, R2 Technology, Inc., iontherapeutics, Inc., Complete Genomics, Inc. and Transcept Pharmaceuticals, Inc. He serves as Legal Counsel at Limerick BioPharma, Inc. He serves as Executive ...

Corporate Headquarters

1003 West Cutting Boulevard
Point Richmond, California 94804

United States

Phone: 510-215-3500
Fax: --

Board Members Memberships

Former Director
Director
Former Secretary and Director
Former Corporate Counsel, Secretary and Director
Former Director
Corporate Secretary and Director
1994-N/A
Former Director
1999-N/A
Former Director
1999-N/A
Former Director
2000-N/A
Former Director
2001-N/A
Former Director and Member of Nominating & Governance Committee
2002-2008
Former Independent Director, Chairman of Executive Compensation Committee and Member of Corporate Governance & Nominating Committee

Education

JD 1973
Harvard University
BA 1969
University of California Berkeley

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
G. Tyson Tuttle Chief Executive Officer, Director and Member of Equity Award Committee
Silicon Laboratories Inc.
$513.5K
Gregory S. Lang Chief Executive Officer, President and Director
PMC-Sierra Inc.
$660.0K
Mohan R. Maheswaran Chief Executive Officer, President and Director
Semtech Corporation
$547.0K
Michael R. Hsing Founder, Chairman, Chief Executive Officer and President
Monolithic Power Systems Inc.
$470.4K
Thomas A. Lacey Chief Executive Officer and Director
Tessera Technologies Inc.
$500.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Transcept Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.